arXiv:2502.15646cs.LG2025-02被引 1

用多模型集成提升癌症药物反应预测准确率

Predicting gene essentiality and drug response from perturbation screens in preclinical cancer models with LEAP: Layered Ensemble of Autoencoders and Predictors

  • 采用分层集成策略融合多种基因表达模型的预测结果
  • 在未测试细胞系上显著提升预测性能,计算效率高
  • 可识别影响药物反应的关键生物通路,适合药物研发人员

高通量前临床扰动筛选通过系统性测试遗传、化学或环境扰动在疾病模型中的效应,具有大规模和因果性的优势,为机器学习驱动的药物发现提供了可能。基于此类数据训练的预测模型可用于(i)推断未测试疾病模型的扰动响应,(ii)解析影响扰动响应的生物学背景。现有模型存在可复现性差、泛化能力弱和可解释性不足的问题。为此,我们提出分层集成自编码器与预测器框架(LEAP),一种通用且灵活的集成策略,通过聚合多个回归器的预测结果,这些回归器使用不同的基因表达表示模型训练而成。LEAP在多种建模策略下均显著提升未筛查细胞系的预测性能。特别是,将LEAP应用于扰动特异性LASSO回归器(PS-LASSO)时,在接近顶尖性能的同时实现低计算开销。我们还提出一种结合模型蒸馏与稳定性选择的可解释性方法,用于识别影响扰动响应预测的重要生物通路。该模型有望加速药物发现流程,指导前临床实验优先级,并揭示扰动响应的生物学机制。本文所用代码与数据集均已公开。

原文摘要 · Abstract (English)

High-throughput preclinical perturbation screens, where the effects of genetic, chemical, or environmental perturbations are systematically tested on disease models, hold significant promise for machine learning-enhanced drug discovery due to their scale and causal nature. Predictive models trained on such datasets can be used to (i) infer perturbation response for previously untested disease models, and (ii) characterise the biological context that affects perturbation response. Existing predictive models suffer from limited reproducibility, generalisability and interpretability. To address these issues, we introduce a framework of Layered Ensemble of Autoencoders and Predictors (LEAP), a general and flexible ensemble strategy to aggregate predictions from multiple regressors trained using diverse gene expression representation models. LEAP consistently improves prediction performances in unscreened cell lines across modelling strategies. In particular, LEAP applied to perturbation-specific LASSO regressors (PS-LASSO) provides a favorable balance between near state-of-the-art performance and low computation time. We also propose an interpretability approach combining model distillation and stability selection to identify important biological pathways for perturbation response prediction in LEAP. Our models have the potential to accelerate the drug discovery pipeline by guiding the prioritisation of preclinical experiments and providing insights into the biological mechanisms involved in perturbation response. The code and datasets used in this work are publicly available.

药物发现基因预测模型集成

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。